Royal Bank of Canada:企業の戦略・SWOT・財務情報

◆英語タイトル:Royal Bank of Canada - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C1124
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:58
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Royal Bank of Canada – Strategy, SWOT and Corporate Finance Report
Summary

Royal Bank of Canada – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Royal Bank of Canada (RBC) is a provider of personal and business banking, wealth management, and institutional banking. Personal banking offers deposit services, loans, insurance, credit cards, mortgages, investments, and bancassurance. Business banking comprises loans, deposit services, payments and receipts, business advisory, invoicing and accounting, business insights, and business registration and incorporation services. Wealth management offers tax and estate planning, retirement and investment management, and wealth management strategies. Institutional banking contains investor services, global asset management, and capital markets. It operates through a network of branch offices, ATMs, and online portals and serves individual, business, SME, institutional, and high and ultra-high net worth individual clients. The bank operates in North America, the Caribbean, and Europe. RBC is headquartered at Toronto, Canada.

Scope

- Detailed information on Royal Bank of Canada required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Royal Bank of Canada in the form of a SWOT analysis
- An in-depth view of the business model of Royal Bank of Canada including a breakdown and examination of key business segments
- Intelligence on Royal Bank of Canada’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Royal Bank of Canada, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Royal Bank of Canada and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Royal Bank of Canada as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Royal Bank of Canada’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 6
Royal Bank of Canada: Company Overview 10
Royal Bank of Canada: Overview and Key Facts 10
Royal Bank of Canada: Overview 10
Royal Bank of Canada: Key Facts 10
Royal Bank of Canada: Key Employees 12
Royal Bank of Canada: Key Employee Biographies 14
Royal Bank of Canada: Major Products and Services 16
Royal Bank of Canada: Company History 20
Royal Bank of Canada: Management Statement 25
Royal Bank of Canada: Locations and Subsidiaries 27
Royal Bank of Canada: Key Competitors 30
Royal Bank of Canada: Company Analysis 31
Royal Bank of Canada: Business Description 31
Royal Bank of Canada: SWOT Analysis 32
Royal Bank of Canada: SWOT Overview 32
Royal Bank of Canada: Strengths 32
Royal Bank of Canada: Weaknesses 33
Royal Bank of Canada: Opportunities 34
Royal Bank of Canada: Threats 35
Royal Bank of Canada: Corporate Financial Deals Activity 36
Royal Bank of Canada: Financial Deals Overview 36
Royal Bank of Canada: Targets and Partners 38
Royal Bank of Canada: Top Deals 2014 – 2018YTD* 39
Royal Bank of Canada: Advisors 40
Royal Bank of Canada: Top Legal Advisors 40
Royal Bank of Canada: Top Financial Advisors 40
Royal Bank of Canada: Mergers and Acquisitions 42
Royal Bank of Canada: Corporate Venturing 43
Royal Bank of Canada: Capital Raising 44
Royal Bank of Canada: Divestments 45
Royal Bank of Canada: Recent Developments 46
Royal Bank of Canada: News and Events Summary 46
Royal Bank of Canada: Contracts 51
Royal Bank of Canada: Financial Deals 52
Royal Bank of Canada: IT Spending Announcements 52
Royal Bank of Canada: Strategy and Operations 54
Appendix 56
Contact Us 56
Methodology 56
About MarketLine 57

List of Tables
Table 1: Royal Bank of Canada: Key Facts
Table 2: Royal Bank of Canada: Key Employees
Table 3: Royal Bank of Canada: Locations and Subsidiaries
Table 4: Royal Bank of Canada: Key Competitors
Table 5: Royal Bank of Canada: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Royal Bank of Canada: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: Royal Bank of Canada: M&A Average Deal Size - Value (US$m)
Table 8: Royal Bank of Canada: Targets and Partners
Table 9: Royal Bank of Canada: Top Deals 2014 - 2018YTD*
Table 10: Royal Bank of Canada: Legal Advisor Ranking by Value (US$m)
Table 11: Royal Bank of Canada: Financial Advisor Ranking by Value (US$m)
Table 12: Royal Bank of Canada: M&A Volume and Value Trend (2014 - YTD*2018)
Table 13: Royal Bank of Canada: M&A Activity by Geography (2014 - YTD*2018)
Table 14: Royal Bank of Canada: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Table 15: Royal Bank of Canada: Corporate Venturing by Geography (2014 - YTD*2018)
Table 16: Royal Bank of Canada: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 17: Royal Bank of Canada: Capital Raising by Deal Type (2014 - YTD*2018)
Table 18: Royal Bank of Canada: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 19: Royal Bank of Canada: Divestments by Geography (2014 - YTD*2018)
Table 20: Royal Bank of Canada: News and Events Summary
Table 21: Royal Bank of Canada: Contracts
Table 22: Royal Bank of Canada: Financial Deals
Table 23: Royal Bank of Canada: IT Spending Announcements
Table 24: Royal Bank of Canada: Strategy and Operations

List of Figures
Figure 1: Royal Bank of Canada: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Royal Bank of Canada: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: Royal Bank of Canada: M&A Average Deal Size - Value (US$m)
Figure 4: Royal Bank of Canada: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 5: Royal Bank of Canada: M&A Activity by Geography (2014 - YTD*2018)
Figure 6: Royal Bank of Canada: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Figure 7: Royal Bank of Canada: Corporate Venturing by Geography (2014 - YTD*2018)
Figure 8: Royal Bank of Canada: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 9: Royal Bank of Canada: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 10: Royal Bank of Canada: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 11: Royal Bank of Canada: Divestments by Geography (2014 - YTD*2018)

★海外企業調査レポート[Royal Bank of Canada:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Procurri Corporation Limited (BVQ):企業の財務・戦略的SWOT分析
    Procurri Corporation Limited (BVQ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Cushman & Wakefield Inc:企業のM&A・事業提携・投資動向
    Cushman & Wakefield Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Cushman & Wakefield Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • INRange Systems Inc-医療機器分野:企業M&A・提携分析
    Summary INRange Systems Inc (INRange) is a medical device company that develops and markets remote management systems for the healthcare sector. The company provides remote medication management system to improve adherence to medication therapy by remotely managing, storing, delivering, and monitori …
  • Newfield Exploration Company:企業のM&A・事業提携・投資動向
    Newfield Exploration Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Newfield Exploration Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • Global Power Equipment Group Inc-エネルギー分野:企業M&A・提携分析
    Summary Global Power Equipment Group Inc (Global Power) is a power company that manufactures and distributes auxiliary equipment. The company offers products such as gas and steam turbine auxiliary products, control houses and generator enclosures. It provides repair and maintenance, modification an …
  • Ngai Hing Hong Co Ltd (1047)
    Ngai Hing Hong Co Ltd (1047) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Memry Corp:企業の戦略的SWOT分析
    Memry Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Vilniaus Degtine AB:企業の戦略・SWOT・財務情報
    Vilniaus Degtine AB - Strategy, SWOT and Corporate Finance Report Summary Vilniaus Degtine AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • bioLytical Laboratories Inc:企業の製品パイプライン分析
    Summary bioLytical Laboratories Inc (bioLytical) operates as a medical device company that develops and manufactures HIV diagnostic products. The company provides products such as insti HIV-1 and HIV-2 antibody test and insti HIV-1 and HIV-2 test controls. Its product line offers test result that tr …
  • Genera Biosystems Ltd (GBI):製品パイプライン分析
    Summary Genera Biosystems Ltd (GBL) is a developer and commercializer of multiplexed molecular diagnostic testing products. The company offers RTIplex and PapType molecular diagnostic test. Its RTIplex is a multiplexed and automated PCR based test for detection of viral and bacterial respiratory pat …
  • Martin Mathew & Co. Ltd.:企業の戦略・SWOT・財務情報
    Martin Mathew & Co. Ltd. - Strategy, SWOT and Corporate Finance Report Summary Martin Mathew & Co. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • P. H. Glatfelter Co (GLT):企業の財務・戦略的SWOT分析
    P. H. Glatfelter Co (GLT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Theravectys SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Theravectys SA (TheraVectys) is a clinical development biotech company that develops new generation therapeutic vaccines and immunotherapies. The company develops viral vectors vaccines to support body and prepare against future infections by pre-exposing immune system to partial, dead, inac …
  • TIE Kinetix NV (TIE):企業の財務・戦略的SWOT分析
    TIE Kinetix NV (TIE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Northwest Territories Power Corporation:発電所・企業SWOT分析
    Northwest Territories Power Corporation - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, informat …
  • Space Hellas S.A. (SPACE):企業の財務・戦略的SWOT分析
    Space Hellas S.A. (SPACE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Fluidigm Corp (FLDM)-製薬・医療分野:企業M&A・提携分析
    Summary Fluidigm Corp (Fluidigm) formerly known as Mycometrix Corporation, is a biotechnology company which manufactures life-science tools and creates technologies based on microfluidics and mass cytometry. The company’s products systems include biomark HD system, access array system, C1 system, ca …
  • Valecha Engineering Ltd:戦略・SWOT・企業財務分析
    Valecha Engineering Ltd - Strategy, SWOT and Corporate Finance Report Summary Valecha Engineering Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Bajaj Allianz Life Insurance Company Ltd:企業の戦略・SWOT・財務分析
    Bajaj Allianz Life Insurance Company Ltd - Strategy, SWOT and Corporate Finance Report Summary Bajaj Allianz Life Insurance Company Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Clinuvel Pharmaceuticals Ltd (CUV):製薬・医療:M&Aディール及び事業提携情報
    Summary Clinuvel Pharmaceuticals Ltd (Clinuvel Pharmaceuticals) is a biopharmaceutical company which focuses on the development of drugs for the treatment of severe skin disorders. Its lead product candidate, Scenesse (afamelanotide) is a first-in-class drug targeting erythropoietic protoporphyria ( …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆